A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.
about
Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Bioequivalence study between a fixed-dose single-pill formulation of nebivolol plus hydrochlorothiazide and separate formulations in healthy subjects using high-performance liquid chromatography coupled to tandem mass spectrometry.Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.
P2860
A Single-Center, Open-Label, 3-Way Crossover Trial to Determine the Pharmacokinetic and Pharmacodynamic Interaction Between Nebivolol and Valsartan in Healthy Volunteers at Steady State.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@ast
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@en
type
label
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@ast
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@en
prefLabel
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@ast
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@en
P2093
P2860
P1476
A Single-Center, Open-Label, 3 ...... hy Volunteers at Steady State.
@en
P2093
Chun Lin Chen
Daksha Desai-Krieger
Harold M Wright
Majid Kerolous
Parviz Ghahramani
Stephan Ortiz
P2860
P304
P356
10.1097/MJT.0000000000000247
P577
2015-04-07T00:00:00Z